Therapeutic efficacy of antisense oligonucleotides in mouse models of CLN3 Batten disease

Journal: Nature Medicine

Published: 2020-07-27

DOI: 10.1038/s41591-020-0986-1

Affiliations: 6

Authors: 10

Go to article
Institutions Share
Chicago Medical School (CMS), RFUMS, United States of America (USA) 0.40
Ionis Pharmaceuticals, Inc., United States of America (USA) 0.30
Sanford Research Pediatrics and Rare Diseases, United States of America (USA) 0.15
School of Graduate and Postdoctoral Studies (SGPS), RFUMS, United States of America (USA) 0.10
Department of Pediatrics, USD, United States of America (USA) 0.05

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER